Low Cylinder Toric
Information source: Alcon Research
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cataracts
Intervention: Toric IOL (SN60T3) (Device)
Phase: Phase 4
Status: Completed
Sponsored by: Alcon Research
Summary
Study evaluates the visual outcomes and patient satisfaction after implantation of a toric
intraocular lens (IOL).
Clinical Details
Official title: Evaluation of the Acrysof Toric Model SN60T3 Intraocular Lens in Patients With Predicted Residual Corneal Astigmatism Between 0.75 and 1.03 Diopters (D)
Study design: Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: Uncorrected Distance Visual AcuityBest Corrected Distance Visual Acuity Residual Refractive Cylinder
Secondary outcome: Patient Satisfaction Survey
Eligibility
Minimum age: 21 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Diagnosed with Cataracts
- Predicted residual corneal astigmatism between 0. 75 and 1. 03 Diopters (D)
Exclusion Criteria:
- Preoperative ocular pathology
- Planned monovision
Locations and Contacts
Alcon Call Center for Trial Locations, Fort Worth, Texas 76134, United States
Additional Information
Starting date: June 2007
Last updated: March 25, 2010
|
